CAMBRIDGE, Mass.–(BUSINESS WIRE)–Fulcrum Therapeutics, a biotechnology company focused on discovering and developing therapies to rebalance …
Read More »
TORONTO–(BUSINESS WIRE)–FSD Pharma Inc. (CSE: HUGE) (OTCQB: FSDDF) (FRA: 0K9) (“FSD Pharma” or the “Company”) …
Read More »
KENILWORTH, N.J.–(BUSINESS WIRE)–Merck (NYSE: MRK), known as MSD outside the United States and Canada, today …
Read More »
INDIANAPOLIS, April 22, 2019 /PRNewswire/ — Eli Lilly and Company(NYSE: LLY) announced today that Taltz® (ixekizumab) met the primary …
Read More »
INDIANAPOLIS and LA JOLLA, Calif., April 22, 2019 /PRNewswire/ — Eli Lilly and Company (NYSE: LLY) and Avidity Biosciences, Inc. today announced a …
Read More »
The U.S. Food and Drug Administration today permitted marketing of the first medical device to …
Read More »
NEW YORK & INDIANAPOLIS–(BUSINESS WIRE)–Pfizer Inc. (NYSE:PFE) and Eli Lilly and Company (NYSE:LLY) today announced …
Read More »
PLYMOUTH MEETING, Pa., April 18, 2019 /PRNewswire/ — Inovio Pharmaceuticals, Inc. (NASDAQ: INO) announced today …
Read More »
GAITHERSBURG, Md.–(BUSINESS WIRE)–Viela Bio today announced that the U.S. Food and Drug Administration (FDA) has …
Read More »
STAINES-UPON-THAMES, United Kingdom, April 18, 2019 /PRNewswire/ — Mallinckrodt plc (NYSE: MNK), a leading global …
Read More »
BOSTON & LOUISVILLE, Ky.–(BUSINESS WIRE)–Talaris Therapeutics, Inc., formerly Regenerex, a privately held biotechnology company developing …
Read More »
Lille (France), Cambridge (Massachusetts, United States), April 18, 2019 – GENFIT (Nasdaq and Euronext: GNFT – …
Read More »
MEMPHIS, Tenn., April 17, 2019 /PRNewswire/ — Gene therapy developed at St. Jude Children’s Research …
Read More »
SAN DIEGO and PENNINGTON, N.J., April 17, 2019 /PRNewswire/ — OncoSec Medical Incorporated (OncoSec) (NASDAQ: …
Read More »
SANTA CLARA, Calif.–(BUSINESS WIRE)–Agilent Technologies Inc. (NYSE: A) today announced that the U.S. Food and Drug …
Read More »
Specialty Pharma Journal Specialty, Precision & Technology
